News
Pharmaceutical Technology on MSN7d
Teva brings first generic GLP-1 to US market with Saxenda copycat approval
Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs ...
In separate announcements, Form Health and 9amHealth said they would provide patients seeking support for obesity care with ...
In December 2024, Teva also secured FDA approval for the other liraglutide brand Victoza, indicated for type 2 diabetes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback